1. Home
  2. OTLY vs PRTC Comparison

OTLY vs PRTC Comparison

Compare OTLY & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLY
  • PRTC
  • Stock Information
  • Founded
  • OTLY 1994
  • PRTC 2015
  • Country
  • OTLY Sweden
  • PRTC United States
  • Employees
  • OTLY N/A
  • PRTC N/A
  • Industry
  • OTLY Packaged Foods
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • OTLY Consumer Staples
  • PRTC Health Care
  • Exchange
  • OTLY Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • OTLY 518.0M
  • PRTC 428.7M
  • IPO Year
  • OTLY 2021
  • PRTC N/A
  • Fundamental
  • Price
  • OTLY $15.79
  • PRTC $17.78
  • Analyst Decision
  • OTLY Buy
  • PRTC
  • Analyst Count
  • OTLY 5
  • PRTC 0
  • Target Price
  • OTLY $19.75
  • PRTC N/A
  • AVG Volume (30 Days)
  • OTLY 128.8K
  • PRTC 1.6K
  • Earning Date
  • OTLY 10-29-2025
  • PRTC 08-28-2025
  • Dividend Yield
  • OTLY N/A
  • PRTC N/A
  • EPS Growth
  • OTLY N/A
  • PRTC N/A
  • EPS
  • OTLY N/A
  • PRTC 0.20
  • Revenue
  • OTLY $842,996,000.00
  • PRTC $6,391,000.00
  • Revenue This Year
  • OTLY $3.73
  • PRTC N/A
  • Revenue Next Year
  • OTLY $4.71
  • PRTC N/A
  • P/E Ratio
  • OTLY N/A
  • PRTC $8.27
  • Revenue Growth
  • OTLY 3.63
  • PRTC 1265.60
  • 52 Week Low
  • OTLY $6.00
  • PRTC $13.30
  • 52 Week High
  • OTLY $19.13
  • PRTC $24.99
  • Technical
  • Relative Strength Index (RSI)
  • OTLY 53.17
  • PRTC 51.14
  • Support Level
  • OTLY $14.31
  • PRTC $17.00
  • Resistance Level
  • OTLY $16.04
  • PRTC $17.75
  • Average True Range (ATR)
  • OTLY 0.98
  • PRTC 0.20
  • MACD
  • OTLY 0.21
  • PRTC -0.09
  • Stochastic Oscillator
  • OTLY 79.30
  • PRTC 49.10

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: